FBI NGI February 2019 Fact Sheet Statistics:

• The FBI Next Generation Identification (NGI) database
contains the fingerprints of over 140 million individuals (both
civil and criminal).
• The percent of Tenprint Rapsheet Request (TPRS) system responses completed within 20 seconds is 97.26%. (Avg. FY 2019)

In Touch With Your World

FREEDOM TO TRAVEL ABROAD

For the Pharma Technology Industry

FBI fingerprint-based background checks are increasingly required for
U.S. Citizens to live, work and travel overseas in many countries such
as China, South Korea, Australia, South Africa, Spain and Israel.
Accurate Biometrics is an authorized FBI Channeler, providing access
to FBI Identity History Summary Checks (IdHS), or Departmental Orders
(556-73).
Our expertise will assist your company:

  • Obtain access to Identity History Summary Checks for Visa requirements direct from the FBI CJIS
  • National U.S. Collection Network, over 700 locations in 50 states
  • SAME DAY International fingerprint card processing
  • Results available within 24 hours
  • Customized solution-based service to public and private companies to meet their fingerprinting needs

For more information on how to improve your current fingerprint process, contact...

Will Peterson 
Director of Business Development
708-887-9258​​​​​​​
wpeterson@accuratebiometrics.com
AccurateBiometrics.com

Go to article: Home | Ingredients on demandGo to article: In this issueGo to article: Scandinavian HealthGo to article: ContentsGo to article: Daiichi JitsugyoGo to article: NewsGo to article: Hapa Company InsightGo to article: Gerteis Company InsightGo to article: GerteisGo to article: The pharma industry briefingGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Scott Gottlieb: achievements of the outgoing FDA commissionerGo to article: CapsugelGo to article: AlpexGo to article: Can Pharmaoffer become the Amazon of pharma raw materials?Go to article: Molnar Company InsightGo to article: MolnarGo to article: Is growth factor protein the future of Parkinson’s treatment?Go to article: AEB Company Insight Go to article: AEB Go to article: CBD: the myth, the magic and the real deal drugsGo to article: Swiss WorldCargoGo to article: Moehs Iberica SLGo to article: Could a pregnancy protein hold promise for new drugs?Go to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Antimicrobial resistance: sewage samples reveal bad sanitation as a key driverGo to article: BEAGo to article: 3MGo to article: PfanstiehlGo to article: EventsGo to article: Richter HelmGo to article: Event: CPhl KoreaGo to article: TSS Company InsightGo to article: TSS ABGo to article: Next issueGo to article: Baxter